Biotech

All Articles

Biogen, UCB record period 3 lupus gain after stopping working earlier test

.Biogen as well as UCB's gamble on developing right into period 3 on the back of an unsuccessful res...

Aptadir really hopes brand new RNA inhibitors can turn around tricky cancers cells

.Italian biotech Aptadir Therapies has actually introduced along with the guarantee that its own pip...

Wave surfs DMD results to regulators' doors, delivering stock up

.Surge Lifestyle Sciences has actually satisfied its own target in a Duchenne muscular dystrophy (DM...

Sanofi picks new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma fold, using ...

Achilles droplets tissue treatment course, prepares for cutbacks after overlooking 'industrial feasibility' goals

.Achilles Rehabs has actually shreded its method. The British biotech is stopping work on its own cl...

Aligos trumpets phase 2 MASH win, reducing liver fat around 46%

.Aligos Rehabs is declaring a midstage gain in metabolic-dysfunction linked steatohepatitis (MASH) a...

Basilea scores $268M BARDA financing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work developing brand new antifungals has actually gotten a significant inc...

Capricor offers Europe civil rights to late-stage DMD therapy for $35M

.Having presently scooped up the united state legal rights to Capricor Therapies' late-stage Duchenn...

FDA scraps adcomm for Applied's unusual ailment medication

.After pushing the choice meeting for Applied Rehabs' metabolic problem medication govorestat, the F...

Novo inks $600M NanoVation offer to analyze hereditary medications ex-liver

.Novo Nordisk is actually proceeding its push right into hereditary medicines, agreeing to pay NanoV...